Page 373«..1020..372373374375..»

GSK, MedTrust launch iPhone/iPad app for cancer trials

By admin

GlaxoSmithKline has teamed up with MedTrust Online,  provider of specialist data and technology to oncologists, to launch CancerTrialsApp, described as “the first free geo locating cancer clinical trials application” for the Apple iPhone and iPad.The application enables cancer doctors to find and share with their patients information about experimental therapies in clinical trials

To Read More: GSK, MedTrust launch iPhone/iPad app for cancer trials
categoriaUncategorized commentoComments Off on GSK, MedTrust launch iPhone/iPad app for cancer trials | dataJune 11th, 2010
Read All

‘Splice’ creepy in more than one way – Tulsa World

By admin

Opposing Views'Splice' creepy in more than one wayTulsa World... and moral implications abound in "Splice," the latest twist on the Frankenstein-monster story, full of genetic engineering and sudsy soap opera drama. ...With provocative start, 'Splice' sees morbid endBangor Daily NewsREVIEW: 'Splice' cuts into medical fieldSioux City JournalMovie Review: "Splice" - Disturbing and LovelyOpposing Viewsall 10 […]

To Read More: ‘Splice’ creepy in more than one way – Tulsa World
categoriaUncategorized commentoComments Off on ‘Splice’ creepy in more than one way – Tulsa World | dataJune 11th, 2010
Read All

Dyadic in deal to license biotechnology – Bizjournals.com

By admin

Bizjournals.comDyadic in deal to license biotechnologyBizjournals.comEmalfarb said he's working on a final license agreement with EnGen Bio, which is led by Mark R. Alfenito, a biotechnology veteran who has completed more ...Dyadic International Signs Term Sheet for Potential Exclusive Outlicense of C1 ...PR Newswire (press release)all 11 news articles »

To Read More: Dyadic in deal to license biotechnology – Bizjournals.com
categoriaUncategorized commentoComments Off on Dyadic in deal to license biotechnology – Bizjournals.com | dataJune 10th, 2010
Read All

International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’

By admin

International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 at 10:00 a.m. PST. ISCO Chairman, Mr. Kenneth Aldrich will discuss the Company's newly issued […]

To Read More: International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’ | dataJune 10th, 2010
Read All

Genzyme fends off looming proxy fight – Boston Globe

By admin

Boston GlobeGenzyme fends off looming proxy fightBoston GlobeActivist shareholder Carl C. Icahn has completed deals with two big Cambridge biotechnology companies — Biogen Idec and Genzyme. ...Genzyme, Icahn reach accord, ending proxy fightReuters (press release)Genzyme and Carl Icahn Reach AgreementMarketWatch (press release)Icahn withdraws Genzyme board nomineesFinancial TimesWall Street Journal -BusinessWeek -The Associated Pressall 180 news articles »

To Read More: Genzyme fends off looming proxy fight – Boston Globe
categoriaUncategorized commentoComments Off on Genzyme fends off looming proxy fight – Boston Globe | dataJune 10th, 2010
Read All

‘Splice’ Is A Stylish, Scary Movie – Arizona Reporter

By admin

ABC News'Splice' Is A Stylish, Scary MovieArizona ReporterGenetic engineering is at the forefront of science these days, so it's not surprising that brilliant biochemists Clive (Adrien Brody) and Elsa (Sarah ...AT THE MOVIES|SpliceKawartha Media GroupPlaying The Genetics Game With "Splice"RTT Newsall 64 news articles »

To Read More: ‘Splice’ Is A Stylish, Scary Movie – Arizona Reporter
categoriaUncategorized commentoComments Off on ‘Splice’ Is A Stylish, Scary Movie – Arizona Reporter | dataJune 9th, 2010
Read All

Genetically Engineered Trees Coming To Georgia – GPB

By admin

Washington PostGenetically Engineered Trees Coming To GeorgiaGPBSouth Carolina based ArborGen uses genetic engineering to grow more trees. They received USDA approval to plant 28 plots of their ...Paper industry tests genetically altered treesThe Associated PressPaper Industry Eyes Genetically Engineered Eucalyptus to Conserve ForestsTreehuggerall 308 news articles »

To Read More: Genetically Engineered Trees Coming To Georgia – GPB
categoriaUncategorized commentoComments Off on Genetically Engineered Trees Coming To Georgia – GPB | dataJune 9th, 2010
Read All

Anger grows at restrive biotechnology patents – Adelaidenow

By admin

ABC OnlineAnger grows at restrive biotechnology patentsAdelaidenowBIOTECHNOLOGY companies that have patented human genes are monopolising the market, stifling important research and stopping patients getting crucial tests, ...Cancer gene case spooks biotech companiesABC OnlineBRCA1 gene patent challenged in Australian courtAustralian Life ScientistShould Companies Be Allowed To Patent Breast Cancer Gene?Politics Daily (blog)Sydney Morning Heraldall 25 news […]

To Read More: Anger grows at restrive biotechnology patents – Adelaidenow
categoriaUncategorized commentoComments Off on Anger grows at restrive biotechnology patents – Adelaidenow | dataJune 9th, 2010
Read All

International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office

By admin

International Stem Cell Corporation (OTCBB:ISCO), http://www.intlstemcell.com, announced today that the United States Patent and Trademark Office (USPTO) has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells (hpSC). Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching […]

To Read More: International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office | dataJune 9th, 2010
Read All

Talecris agrees to $3.4 bln bid by Spain’s Grifols – MarketWatch

By admin

RTT NewsTalecris agrees to $3.4 bln bid by Spain's GrifolsMarketWatchTEL AVIV (MarketWatch) -- Talecris Biotherapeutics (NASDAQ:TLCR) , the Research Triangle Park, NC, biotechnology firm, definitively agreed to be acquired by ...Grifols To Pay $3.4 Bln In Cash, Shares For TalecrisWall Street JournalWSJ: Spain's Grifols In Talks To Buy Talecris Biotherapeutics For About $3 Bln ...Daily […]

To Read More: Talecris agrees to $3.4 bln bid by Spain’s Grifols – MarketWatch
categoriaUncategorized commentoComments Off on Talecris agrees to $3.4 bln bid by Spain’s Grifols – MarketWatch | dataJune 7th, 2010
Read All

How Real is the Science Behind ‘Splice’? – Wall Street Journal (blog)

By admin

CBC.caHow Real is the Science Behind 'Splice'?Wall Street Journal (blog)Many scientists and corporations are hailing recent breakthroughs in the field of biotechnology. Some research opponents, such as the Canada-based ETC Group ...Movie Review: SpliceGeeks of Doom (blog)all 40 news articles »

To Read More: How Real is the Science Behind ‘Splice’? – Wall Street Journal (blog)
categoriaUncategorized commentoComments Off on How Real is the Science Behind ‘Splice’? – Wall Street Journal (blog) | dataJune 6th, 2010
Read All

CSCs responsible for metastasis identified

By admin

Cancer stem cells responsible for metastasis identified: HK study, Xinhua News Agency, June 4, 2010. Excerpt: Hong Kong researchers have identified a subset of cancer stem cells responsible for metastasis in human colorectal cancer which can help better predict the prognosis and design a more suitable treatment for patients, according to a study made public […]

To Read More: CSCs responsible for metastasis identified
categoriaStem Cell Therapy commentoComments Off on CSCs responsible for metastasis identified | dataJune 6th, 2010
Read All

Out of Frame: Splice – DCist.com

By admin

Globe and MailOut of Frame: SpliceDCist.comBetter living through genetic engineering takes a serious hit in Vincenzo Natali's Splice, a seriously creepy and surprisingly effective science-gone-awry ...Splice (2008)New York TimesSplice ReviewHeavy.com (blog)Roger Qbert Reviews “Splice”Review St. Louis (blog)Television Without Pity -Seattle Times -The Catholic Spiritall 707 news articles »

To Read More: Out of Frame: Splice – DCist.com
categoriaUncategorized commentoComments Off on Out of Frame: Splice – DCist.com | dataJune 4th, 2010
Read All

Exelixis signs financing deals worth $160 million – BusinessWeek

By admin

RTT NewsExelixis signs financing deals worth $160 millionBusinessWeekBiotechnology company Exelixis Inc. said Thursday it entered two financing deals for a combined $160 million. The company said it signed a deal with Silicon ...Will Exelixis Hog Limelight At ASCO?RTT NewsExelixis to Raise $160 Million through Financing Transactions with Silicon ...MarketWatch (press release)all 38 news articles »

To Read More: Exelixis signs financing deals worth $160 million – BusinessWeek
categoriaUncategorized commentoComments Off on Exelixis signs financing deals worth $160 million – BusinessWeek | dataJune 4th, 2010
Read All

Amgen Bets on Bone Drug to Revive Growth – Wall Street Journal

By admin

The Money TimesAmgen Bets on Bone Drug to Revive GrowthWall Street JournalAmgen Inc. has become the biotechnology industry's most valuable company on the shoulders of drugs that strengthen the blood. ...Options Brief: Amgen (AMGN) Calls Fly Following FDA ApprovalWall Street Pit (blog)Ahead of the Bell: Amgen rises on Prolia approvalBusinessWeekAnother boost for Amgen as US […]

To Read More: Amgen Bets on Bone Drug to Revive Growth – Wall Street Journal
categoriaUncategorized commentoComments Off on Amgen Bets on Bone Drug to Revive Growth – Wall Street Journal | dataJune 3rd, 2010
Read All

Splice (2008) – New York Times

By admin

CBC.caSplice (2008)New York Times... horror movie about love and monsters in the age of genetic engineering, are Adrien Brody and Sarah Polley, a well-matched pair of earthbound oddities. ...Movie review 'Splice': Thriller brings a human/animal hybrid to lifeSeattle TimesCatholic movie review - SpliceThe Catholic SpiritSplice (2008)World Report Now (blog)The Post-Standard - Syracuse.com -USA Today -San Francisco Chronicleall […]

To Read More: Splice (2008) – New York Times
categoriaUncategorized commentoComments Off on Splice (2008) – New York Times | dataJune 3rd, 2010
Read All

Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences … – MarketWatch (press release)

By admin

Earthtimes (press release)Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences ...MarketWatch (press release)Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture ...ISTO Technologies, Inc. to Present at the Jefferies 2010 Global Life Sciences ...TapeBeatall 296 news articles »

To Read More: Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences … – MarketWatch (press release)
categoriaUncategorized commentoComments Off on Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences … – MarketWatch (press release) | dataJune 3rd, 2010
Read All

Chemist, biologist wins MIT inventor’s prize – Reuters

By admin

Bradenton HeraldChemist, biologist wins MIT inventor's prizeReutersBOSTON (Reuters) - A University of California chemistry and biology professor whose research is applied widely in biotechnology became on Wednesday the ...Berkeley Professor Wins $500000 Prize for Work in BiotechnologyChronicle of Higher Education (subscription)Biochemist wins $500000 Lemelson-MIT PrizeCNETUC Berkeley Chemical Biologist Wins 'Oscar For Inventors'InventorspotBusiness Wire (press release)all […]

To Read More: Chemist, biologist wins MIT inventor’s prize – Reuters
categoriaUncategorized commentoComments Off on Chemist, biologist wins MIT inventor’s prize – Reuters | dataJune 3rd, 2010
Read All

Phase I clinical trial of ICT-107

By admin

Immune response correlation with progression-free survival in glioblastoma following dendritic cell immunotherapy (ICT-107) by Surasak Phuphanich and 9 co-authors, including Manish Singh, Keith Black and John Wu, J Clin Oncol 28:7s, 2010 (suppl; abstr 2097). To be presented at the 2010 ASCO Annual Meeting, June 06, 2010.Related news releases:ImmunoCellular Therapeutics Ltd. (IMUC) to Present Cancer […]

To Read More: Phase I clinical trial of ICT-107
categoriaStem Cell Therapy commentoComments Off on Phase I clinical trial of ICT-107 | dataJune 3rd, 2010
Read All

When will biotechnology in India be properly regulated? – Daily News & Analysis

By admin

The HinduWhen will biotechnology in India be properly regulated?Daily News & AnalysisBangalore: Who regulates research in biotechnology in India? Who takes care of discrepancies in drug pricing, genetic engineering in plants, or the safety ...BT sector to grow 20%Business StandardBiotech sector set to grow 20% to $5 bnLivemintBT sector to become $5 bn industry soonExpress […]

To Read More: When will biotechnology in India be properly regulated? – Daily News & Analysis
categoriaUncategorized commentoComments Off on When will biotechnology in India be properly regulated? – Daily News & Analysis | dataJune 3rd, 2010
Read All